Seat the cup in second analyzer channer. Add activator F and blood in cup. Start the first platelet mapping test
Add 10 µl of diluted activator (activator F) from p1 vial and 360 µl of blood from sodium heparin vial, in the cup with the pipette. Mix them well [ Figure 7 ].
Start second platelet mapping assay with adenosine diphosphate activator
Once the MA value of first platelet mapping assay is observed, start the second test by adding 10 µl of activator F (p1 vial), 10 µl of ADP activator (p2 vial), and 360 µl of blood in the cup [ Figure 8 ].
Start third platelet mapping assay with arachidonic acid activator
Once the MA value of the second platelet Thromboelastography (TEG) platelet mapping assay measures maximal amplitude (MA) of clot firmness, reflecting maximal platelet function. The assay detects the reduction in platelet function, by antiplatelet medications, and presents it as percentage inhibition/ aggregation.
Steps of thromboelastography platelet mapping assay Login and perform e-test Login to the TEG software by entering the username and password. Perform e-test for the two channels by putting TEG analyzer lever on test mode. Once the e-test is OK, put the lever back on load mode. Enter patient details and activator used in the channel [ Figure 1 ].
Seat the cup in analyzer
Place cup in analyzer seat and slide the carrier up. Lock the pin with pusher by pressing 2-3 times and slide the carrier down. Seat the cup in analyzer [ Figure 2 ].
Collect patient blood in thromboelastography kaolin vial and sodium heparin vial
Put patient blood in vial containing kaolin activator up to mark one for basic TEG and in sodium heparin vial for platelet mapping [ Figure 3 ].
Add 10 µl of calcium chloride and 360 µl blood in a cup with specially designed pipettes [ Figure 4 ].
Start the basic thromboelastography test
Slide the carrier up, put the lever on test mode and start the basic TEG test using only kaolin activator. Note the R, K, MA, lysis thirty values [ Figure 5 ]. mapping assay is observed, start the third test by adding 10 µl of activator F (p1 vial), 10 µl of AA activator (p3
